rxstat › Shortages › Baclofen
Baclofen shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Baclofen products are in shortage in Canada (1 of 17 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
May 26, 2023
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageBACLOFEN INJECTION
0.05MG · SOLUTION · HIKMA CANADA LIMITED
DIN 02457059 · since May 26, 2023, no end estimate · Delay in shipping of the drug.
DiscontinuedBACLOFEN INTRATHECAL
0.05MG · SOLUTION · AVIR PHARMA INC.
DIN 02485494
ResolvedBACLOFEN
10MG · TABLET · SANIS HEALTH INC
DIN 02287021 · ended Jan 8, 2025 · Disruption of the manufacture of the drug.
ResolvedBACLOFEN
10MG · TABLET · SANIS HEALTH INC
DIN 02287021 · ended Oct 7, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-BACLOFEN
10MG · TABLET · APOTEX INC
DIN 02139332 · ended Aug 29, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-BACLOFEN
20MG · TABLET · APOTEX INC
DIN 02139391 · ended May 23, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-BACLOFEN
10MG · TABLET · APOTEX INC
DIN 02139332 · ended May 23, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-BACLOFEN
10MG · TABLET · APOTEX INC
DIN 02139332 · ended May 23, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-BACLOFEN
20MG · TABLET · APOTEX INC
DIN 02139391 · ended Dec 21, 2023 · Disruption of the manufacture of the drug.
ResolvedAPO-BACLOFEN
10MG · TABLET · APOTEX INC
DIN 02139332 · ended Dec 15, 2023 · Disruption of the manufacture of the drug.
AvoidedBACLOFEN
10MG · TABLET · SANIS HEALTH INC
DIN 02287021 · ended Nov 30, 2023 · Disruption of the manufacture of the drug.
ResolvedBACLOFEN
10MG · TABLET · SANIS HEALTH INC
DIN 02287021 · ended Nov 23, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 46 reports. All reports are on file with Health Canada.
What's happening
Baclofen is currently affected by an active shortage report filed with Health Canada by HIKMA CANADA LIMITED.
The reported cause is: delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Baclofen is classified under “MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS” (ATC M03BX).
Recent changes
Common questions
When will Baclofen be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Baclofen in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All muscle relaxants, centrally acting agents shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.